Table 1.
Demographic and clinical characteristics of the sample
| FEP patients with persistent AVH (n = 18) | Healthy controls (n = 18) | p value | |
|---|---|---|---|
| Age (mean ± s.d.) | 27.14 ± 5.66 | 26.94 ± 4.31 | 0.91 |
| Gender (Male/female) | 15/3 | 15/3 | 0.73 |
| Marital status (single/married) | 18/0 | 16/2 | 0/492 |
| CPZ equivalents (mean ± s.d.) | 217.85 ± 139.51 | ||
| Duration of untreated psychosis (days) (mean ± s.d.) | 323.92 ± 311.23 | ||
| BAVQ-R scores | |||
| Malevolence (mean ± s.d.) | 11.07 ± 4.54 | ||
| Benevolence (mean ± s.d.) | 4.00 ± 3.28 | ||
| Omnipotence (mean ± s.d.) | 11.57 ± 4.32 | ||
| Resistance (mean ± s.d.) | 19.36 ± 3.67 | ||
| Engagement (mean ± s.d.) | 5.21 ± 3.98 | ||
| TVRS scores (mean ± s.d.) | 17.71 ± 3.47 | ||
| VPDS scores (mean ± s.d.) | 22.93 ± 5.44 | ||
| PSYRATS (auditory hallucination subscale) | |||
| Total score (mean ± s.d.) | 26.86 ± 4.95 | ||
| Emotional domain (mean ± s.d.) | 11.29 ± 3.42 | ||
| Cognitive domain (mean ± s.d.) | 8.64 ± 1.82 | ||
| Physical domain (mean ± s.d.) | 9.79 ± 1.92 | ||
FEP first episode psychosis, AVH auditory verbal hallucinations, CPZ chlorpromazine, BAVQ-R belief about voices questionnaire—revised, TVRS topography of Voices Rating Scale, VPDS Voice Power Differential Scale, PSYRATS Psychotic Symptom Rating Scales